Overview
Lycopene is a naturally occuring red carotenoid pigment that is responsible in red to pink colors seen in tomatoes, pink grapefruit, and other foods . Having a chemical formula of C40H56, lycopene is a tetraterpene assembled from eight isoprene units that are solely composed of carbon and hydrogen. Lycophene may undergo extensive isomerization that allows 1056 theoretical cis-trans configurations; however the all-trans configuration of lycopene is the most predominant isomer found in foods that gives the red hue. Lycopene is a non-essential human nutrient that is classified as a non-provitamin A carotenoid pigment since it lacks a terminal beta ionone ring and does not mediate vitamin A activity. However lycophene is a potent antioxidant molecule that scavenges reactive oxygen species (ROS) singlet oxygen. Tomato lycopene extract is used as a color additive in food products.
Indication
Not Available
Associated Conditions
No associated conditions information available.
Research Report
A Comprehensive Monograph on Lycopene (DB11231): Chemical Profile, Biological Activity, and Clinical Evidence
1.0 Executive Summary
Lycopene is a naturally occurring tetraterpene carotenoid, a lipophilic pigment responsible for the characteristic red color of tomatoes, watermelon, and other fruits. Chemically identified by the formula $C_{40}H_{56}$ and CAS number 502-65-8, it exists predominantly in the all-trans isomeric form in nature, though numerous cis-isomers are formed during processing and are prevalent in human plasma. As a non-provitamin A carotenoid, its biological significance stems not from vitamin activity but from its potent antioxidant and anti-inflammatory properties. Its unique structure, featuring 11 conjugated double bonds, makes it one of the most effective quenchers of singlet oxygen and other reactive oxygen species (ROS) among dietary carotenoids.
The biological mechanisms of lycopene are multifaceted, extending beyond simple antioxidant defense. Evidence indicates that it modulates key cellular pathways involved in inflammation, proliferation, and intercellular communication. It has been shown to suppress pro-inflammatory cytokines, interfere with growth factor signaling, induce cell cycle arrest in cancer cells, and restore gap junctional communication—a process often lost during carcinogenesis. This complex bioactivity forms the basis for its investigation in the prevention of chronic diseases.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2020/12/03 | Phase 2 | Completed | Nourhan M.Aly | ||
2019/05/28 | Phase 2 | UNKNOWN | |||
2017/06/29 | Phase 1 | Completed | Maie Sami tawfik | ||
2017/05/25 | Phase 2 | UNKNOWN | Ospedale San Carlo Borromeo | ||
2015/10/27 | Phase 4 | Completed | |||
2013/09/24 | Phase 1 | Completed | |||
2011/09/29 | Phase 2 | Completed | |||
2009/05/21 | Phase 2 | UNKNOWN | |||
2008/04/10 | Phase 2 | Completed | College of Dental Sciences, India | ||
2007/03/22 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Kids Multi | 329564 | Medicine | A | 2/6/2020 | |
| Total Prostate | 301500 | Medicine | A | 4/3/2018 | |
| USANA HealthPak | 350153 | Medicine | A | 11/30/2020 | |
| Daily Multi Multivitamin | 337216 | Medicine | A | 5/29/2020 | |
| SWISSE PLUS+ ADVANCED CHOLESTEROL PROTECT | 395750 | Medicine | A | 9/9/2022 | |
| Juice Plus+ ESSENTIALS Vegetable Blend | 442970 | Medicine | A | 2/29/2024 | |
| PHARMACY CARE DAILY MULTIVITAMIN | 215746 | Medicine | A | 10/8/2013 | |
| Daily Multi Multivitamin | 443352 | Medicine | A | 3/7/2024 | |
| Essential Health Men's High Potency Multivitamins | 343036 | Medicine | A | 9/5/2020 | |
| Hair, Skin & Nails | 385859 | Medicine | A | 3/18/2022 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.
